Your browser doesn't support javascript.
loading
Calculated panel reactive antibody method for assessing the probability of kidney recipients to receive transplantation / 南方医科大学学报
Journal of Southern Medical University ; (12): 477-481, 2014.
Article in Chinese | WPRIM | ID: wpr-249426
ABSTRACT
<p><b>OBJECTIVE</b>To establish a calculated panel reactive antibody (CPRA) method to analyze the donor-recipient incompatibility rate in PRA-positive kidney recipients and estimate the probability of these recipients to receive kidney transplantation.</p><p><b>METHODS</b>Based on the database of HLA-A, -B, -DR genes and A-B, A-DR, B-DR, A-B-DR haplotype frequencies collected from 2004 donors from Jan 2000 to Dec 2012, we analyzed CPRA in 202 PRA-positive recipients and evaluated the consistency between PRA and CPRA assessments using a CPRA-Java calculator software, which returned a percentage of CPRA (representing the probability of unacceptable HLA in the donor group) after input of HLA-specific antibodies of a PRA-positive recipient.</p><p><b>RESULTS</b>The mean PRA intensity of the 202 PRA-positive recipients was (23.12∓17.83)% with a mean CPRA% of (46.07∓23.30)%. A significant difference was found between the mean PRA% and CPRA% in low sensitized recipients (PRA 0-10%) [(6.87∓2.41)% vs (21.63∓11.75)%, P<0.05) and in moderately sensitized recipients (PRA 10%-30%) [(20.15∓5.70)% vs (50.56∓16.86)%, P<0.05), but not in highly sensitized recipients (PRA>30%); The concordance rates between PRA% and CPRA% in the 3 groups were 19.35% (P<0.05), 10.99% (P<0.05), and 100% (P>0.05), respectively.</p><p><b>CONCLUSIONS</b>Lowly sensitized kidney recipients might have a lower probability of actually receiving a transplant than PRA% shows. A PRA%>30% is a risk factor for kidney transplantation. PRA reflects the sensitized level of a renal recipient, and reliable detection of HLA antibody specificity is of critical importance. CPRA accurately reflects the probability of a recipient to receive a transplant to assist clinicians in predicting the waiting time and selecting the transplant approach.</p>
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Histocompatibility Testing / Kidney Transplantation / Allergy and Immunology / Genetics / Graft Rejection / Graft Survival / Haploidy / HLA Antigens / Methods / Antibodies Type of study: Prognostic study Limits: Humans Language: Chinese Journal: Journal of Southern Medical University Year: 2014 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Histocompatibility Testing / Kidney Transplantation / Allergy and Immunology / Genetics / Graft Rejection / Graft Survival / Haploidy / HLA Antigens / Methods / Antibodies Type of study: Prognostic study Limits: Humans Language: Chinese Journal: Journal of Southern Medical University Year: 2014 Type: Article